- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/01 - Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
Patent holdings for IPC class C12N 15/01
Total number of patents in this class: 961
10-year publication summary
91
|
74
|
48
|
68
|
63
|
62
|
60
|
48
|
49
|
15
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
President and Fellows of Harvard College | 5792 |
50 |
Monsanto Technology LLC | 7905 |
46 |
Stine Seed Farm, Inc. | 769 |
42 |
Chr. Hansen A/S | 979 |
40 |
The General Hospital Corporation | 4517 |
17 |
The Regents of the University of California | 18943 |
15 |
M.S. Technologies LLC | 997 |
15 |
Danisco US Inc. | 1045 |
13 |
Massachusetts Institute of Technology | 9795 |
12 |
DSM IP Assets B.V. | 5856 |
12 |
RIJK Zwaan Zaadteelt en Zaadhandel B.V. | 628 |
12 |
Lesaffre et Compagnie | 765 |
11 |
Novozymes A/S | 3314 |
10 |
The Broad Institute, Inc. | 1584 |
10 |
Syngenta Participations AG | 4970 |
9 |
Sangamo Therapeutics, Inc. | 437 |
8 |
Cellectis | 397 |
6 |
Children's Medical Center Corporation | 1780 |
6 |
Danisco US Inc., Genencor Division | 57 |
6 |
Enza Zaden Beheer B.V. | 245 |
6 |
Other owners | 615 |